MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4

Rintaro Shimazu(Saga Medical School Hospital), Sachiko Akashi(Saga Medical School Hospital), Hirotaka Ogata(Saga Medical School Hospital), Yoshinori Nagai(Saga Medical School Hospital), Kenji Fukudome(Saga Medical School Hospital), Kensuke Miyake(Saga Medical School Hospital), Masao Kimoto(Saga Medical School Hospital)
The Journal of Experimental Medicine
June 7, 1999
Cited by 2,185Open Access
Full Text

Abstract

Toll-like receptor 4 (TLR4) is a mammalian homologue of Drosophila Toll, a leucine-rich repeat molecule that can trigger innate responses against pathogens. The TLR4 gene has recently been shown to be mutated in C3H/HeJ and C57BL/10ScCr mice, both of which are low responders to lipopolysaccharide (LPS). TLR4 may be a long-sought receptor for LPS. However, transfection of TLR4 does not confer LPS responsiveness on a recipient cell line, suggesting a requirement for an additional molecule. Here, we report that a novel molecule, MD-2, is requisite for LPS signaling of TLR4. MD-2 is physically associated with TLR4 on the cell surface and confers responsiveness to LPS. MD-2 is thus a link between TLR4 and LPS signaling. Identification of this new receptor complex has potential implications for understanding host defense, as well as pathophysiologic, mechanisms.


Related Papers

No related papers found

Powered by citation graph analysis